Invention Grant
- Patent Title: Tolerogenic DNA vaccine
-
Application No.: US16395865Application Date: 2019-04-26
-
Publication No.: US11279745B2Publication Date: 2022-03-22
- Inventor: Jay Chaplin , Michael Wijaranakula
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Jianjie Hu
- Main IPC: C07K14/62
- IPC: C07K14/62 ; C12N15/85 ; A61K9/00 ; A61P3/10 ; C07K14/54 ; C07K14/495
Abstract:
The present invention relates to plasmids useful for prevention and/or delay of e.g. type 1 diabetes.
Public/Granted literature
- US20200339650A1 Tolerogenic DNA Vaccine Public/Granted day:2020-10-29
Information query
